Stigmabase is a non-profit internet initiative dedicated to informing and raising awareness on the damaging effects of social exclusion and stigma around the world. The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.

GSK snags first-in-class FDA nod for Rukobia to treat HIV patients who have few options

Rukobia, a first-in-class attachment inhibitor by GlaxoSmithKline's ViiV Healthcare, has won FDA approval to treat multidrug-resistant HIV. (Business ...


View article...